Have a personal or library account? Click to login
First Report of a Familiar MYCBP2 Pathogenic Variant: Expanding the Knowledge of Neurodevelopmental Disorders Cover

First Report of a Familiar MYCBP2 Pathogenic Variant: Expanding the Knowledge of Neurodevelopmental Disorders

Open Access
|Oct 2025

References

  1. Grill B, Murphey RK, Borgen MA. The PHR proteins: intracellular signaling hubs in neuronal development and axon degeneration. Neural Develop. 2016;11(1):1–18.
  2. Opperman KJ, Grill B. RPM-1 is localized to distinct subcellular compartments and regulates axon length in GABAergic motor neurons. Neural Develop. 2014;9:1–15.
  3. Lewcock JW, Genoud N, Lettieri K, Pfaff SL. The ubiquitin ligase Phr1 regulates axon outgrowth through modulation of microtubule dynamics. Neuron. 2007;56(4):604–620.
  4. D'Souza J, Hendricks M, Le Guyader S, Subburaju S, Grunewald B, et al. Formation of the retinotectal projection requires Esrom, an ortholog of PAM (protein associated with Myc). 2005.
  5. Borgen M, Rowland K, Boerner J, Lloyd B, Khan A, Murphey R. Axon termination, pruning, and synaptogenesis in the giant fiber system of Drosophila melanogaster is promoted by highwire. Genetics. 2017;205(3):1229–1245.
  6. Kosmicki JA, Samocha KE, Howrigan DP, Sanders SJ, Slowikowski K, Lek M, et al. Refining the role of de novo protein-truncating variants in neurodevelopmental disorders by using population reference samples. Nat Genet. 2017;49(4):504–510.
  7. Neale BM, Kou Y, Liu L, Ma'Ayan A, Samocha K, Sabo A, et al. Patterns and rates of exonic de novo mutations in autism spectrum disorders. Nature. 2012;485(7397):242–245.
  8. Bertoli-Avella AM, Kandaswamy KK, Khan S, Ordonez-Herrera N, Tripolszki K, et al. Combining exome/genome sequencing with data repository analysis reveals novel gene–disease associations for a wide range of genetic disorders. Genet Med. 2021;23(8):1551–1568.
  9. AlAbdi L., Desbois M., Rusnac DV, Sulaiman RA, Rosenfeld JA, Lalani S, Murdock DR, et al. Loss-of-function variants in MYCBP2 cause neurobehavioural phenotypes and corpus callosum defects. Brain. 2023;146(4):1373–1387.
  10. Chen S, Francioli LC, Goodrich JK, Collins RL, Kanai M, Wang Q, et al. A genomic mutational constraint map using variation in 76,156 human genomes. Nature. 2024;625(7993):92–100.
  11. Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med Off J Am Coll Med Genet. 2015;17(5):405–424. doi:10.1038/gim.2015.30
  12. Xiang J, Peng J, Baxter S, Peng Z. AutoPVS1: An automatic classification tool for PVS1 interpretation of null variants. Hum Mutat. 2020;41(9):1488–1498.
  13. McRae et al. Prevalence and architecture of de novo mutations in developmental disorders. Nature. 2017;542(7642):433–438.
  14. Lin Y, Afshar S, Rajadhyaksha AM, Potash JB, Han S. A machine learning approach to predicting autism risk genes: Validation of known genes and discovery of new candidates. Front Genet. 2020;11:500064.
  15. Bertoli-Avella AM, Kandaswamy KK, Khan S, Ordonez-Herrera N, Tripolszki K, Beetz C, et al. Combining exome/genome sequencing with data repository analysis reveals novel gene–disease associations for a wide range of genetic disorders. Genet Med. 2021;23(8):1551–1568.
  16. Virdee S. An atypical ubiquitin ligase at the heart of neural development and programmed axon degeneration. Neural Regen Res. 2022;17(11):2347.
Language: English
Published on: Oct 8, 2025
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year

© 2025 I Maleva Kostovska, P Noveski, E Sukarova-Angelovska, D Plaseska-Karanfilska, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.